A. Butrisilane Sodium Injection (25 Mg, 0.5 Ml/bottle), 3 Bottles, B. Erapeguademase (genetically Recombinant) Intramuscular Injection Preparation (2.4 Mg, 1.5 Ml/bottle), 22 Bottles, C. Atezolizumab (genetic Recombination) Note (1200? 20.0?/bottle)...
TK ID 498652175
Document Type
Tender Notice
Tender Summary
A. Butrisilane Sodium Injection (25 Mg, 0.5 Ml/bottle), 3 Bottles, B. Erapeguademase (genetically Recombinant) Intramuscular Injection Preparation (2.4 Mg, 1.5 Ml/bottle), 22 Bottles, C. Atezolizumab (genetic Recombination) Note (1200? 20.0?/bottle)...
Action Deadline
15 May 2024